145 related articles for article (PubMed ID: 27724130)
1. Reduction in serum paraoxonase level in newborns with hyperbilirubinemia as a marker of oxidative stress.
Altuner Torun Y; Ertural U; Ergul AB; Karakukcu C; Akin MA
J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2297-2300. PubMed ID: 27724130
[TBL] [Abstract][Full Text] [Related]
2. Investigation on malondialdehyde, S100B, and advanced oxidation protein product levels in significant hyperbilirubinemia and the effect of intensive phototherapy on these parameters.
Sarici D; Gunes T; Yazici C; Akin MA; Korkmaz L; Memur S; Kurtoglu S; Ozturk MA; Sarici SU
Pediatr Neonatol; 2015 Apr; 56(2):95-100. PubMed ID: 25261050
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in neonatal hyperbilirubinemia.
Kumar A; Pant P; Basu S; Rao GR; Khanna HD
J Trop Pediatr; 2007 Feb; 53(1):69-71. PubMed ID: 17158814
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of oxidant and antioxidant status in infants with hyperbilirubinemia and kernicterus.
Doğan M; Peker E; Kirimi E; Sal E; Akbayram S; Erel O; Ocak AR; Tuncer O
Hum Exp Toxicol; 2011 Nov; 30(11):1751-60. PubMed ID: 21393350
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and antioxidant status in neonatal hyperbilirubinemia.
Davutoglu M; Guler E; Olgar S; Kurutas EB; Karabiber H; Garipardic M; Ekerbicer HC
Saudi Med J; 2008 Dec; 29(12):1743-8. PubMed ID: 19082225
[TBL] [Abstract][Full Text] [Related]
6. Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis.
Annagür A; Örs R; Altunhan H; Kurban S; Ertuğrul S; Konak M; Uygun SS; Pekcan S; Erbay E; Mehmetoğlu İ
Pediatr Int; 2015 Aug; 57(4):608-13. PubMed ID: 25488411
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity in clinical follow-up of patients with acute pancreatitis, with particular emphasis on oxidative stress parameters and lipid profile: a prospective pilot trial.
Yuksekdag S; Yuksel E; Topcu A; Karaagac N; Uzun H; Kiziler AR; Ezberci F; Unal E
Libyan J Med; 2019 Dec; 14(1):1595955. PubMed ID: 30914000
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation, DNA damage and total antioxidant status in neonatal hyperbilirubinemia.
Basu S; De D; Dev Khanna H; Kumar A
J Perinatol; 2014 Jul; 34(7):519-23. PubMed ID: 24674982
[TBL] [Abstract][Full Text] [Related]
9. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
10. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
11. [A multicenter randomized controlled study on the efficacy and safety of Yinzhihuang oral solution for the treatment of neonatal indirect hyperbilirubinemia in term newborn infants].
Clinical Research Collaborative Group of Yinzhihuang Oral Solution
Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):663-8. PubMed ID: 22176900
[TBL] [Abstract][Full Text] [Related]
12. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients.
Kotur-Stevuljevic J; Bogavac-Stanojevic N; Jelic-Ivanovic Z; Stefanovic A; Gojkovic T; Joksic J; Sopic M; Gulan B; Janac J; Milosevic S
Atherosclerosis; 2015 Jul; 241(1):192-8. PubMed ID: 26016451
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
Sun G; Wang YL; Liang JF; Du LZ
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
[TBL] [Abstract][Full Text] [Related]
15. Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing.
Hackenhaar FS; Martinez D; Medeiros TM; Klein C; Alabarse PV; Wainstein MV; Gonçalves SC; Benfato MS
Curr Med Chem; 2012; 19(25):4359-66. PubMed ID: 22934769
[TBL] [Abstract][Full Text] [Related]
16. Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia.
Besser I; Perry ZH; Mesner O; Zmora E; Toker A
Isr Med Assoc J; 2010 Apr; 12(4):220-4. PubMed ID: 20803881
[TBL] [Abstract][Full Text] [Related]
17. Effects of hyperbilirubinemia on markers of genotoxicity and total oxidant and antioxidant status in newborns.
Bulut O; Erek A; Duruyen S
Drug Chem Toxicol; 2022 Jan; 45(1):451-455. PubMed ID: 31902249
[TBL] [Abstract][Full Text] [Related]
18. Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy.
Aycicek A; Erel O
J Pediatr (Rio J); 2007; 83(4):319-22. PubMed ID: 17625638
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients.
Varadhan S; Venkatachalam R; Perumal SM; Ayyamkulamkara SS
Arch Razi Inst; 2022 Apr; 77(2):853-859. PubMed ID: 36284944
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.
Harangi M; Seres I; Varga Z; Emri G; Szilvássy Z; Paragh G; Remenyik E
Eur J Clin Pharmacol; 2004 Dec; 60(10):685-91. PubMed ID: 15490140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
